Alterity Therapeutics (PRNAD) Current Leases (2020 - 2025)

Alterity Therapeutics (PRNAD) has reported Current Leases for 6 consecutive years, with $42980.1 the latest figure, recorded in Q4 2025.

• In Q4 2025, Current Leases rose 4.8% year-over-year to $42980.1; the TTM figure through Dec 2025 stood at $42980.1 (up 4.8% YoY), while the FY2025 annual figure was $56707.2, down 19.68% from the prior year.
• Current Leases came in at $42980.1 for Q4 2025 at Alterity Therapeutics, down from $56707.2 in the prior quarter.
• The five-year high for Current Leases was $56707.2 in Q2 2025, with the low at $1071.3 in Q2 2024.
• Average Current Leases over 5 years is $29355.4, with a median of $41011.6 recorded in 2024.
• Across the five-year window, Current Leases plunged 97.4% in 2023 and soared 5193.25% in 2025, its largest moves.
• Year by year, Current Leases stood at $21365.9 in 2021, then surged by 93.2% to $41280.0 in 2022, then tumbled by 97.4% to $1071.8 in 2023, then surged by 3726.53% to $41011.6 in 2024, then increased by 4.8% to $42980.1 in 2025.
• According to Business Quant data, Current Leases over the past three periods registered $42980.1, $56707.2, and $41011.6 for Q4 2025, Q2 2025, and Q4 2024 respectively.